◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › O › OBIO

Orchestra BioMed Holdings, Inc. (OBIO) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-09-11

Orchestra BioMed Holdings, Inc. (OBIO) operates in the Biotechnology industry and is headquartered in New Hope, United States with about 86 employees. Its market capitalization is roughly $349 million. In the fiscal year ended 2025-12-31, OBIO reported $34M in revenue and ($53M) in net income.

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States.

Interactive charts & full statements → Open the OBIO valuation workbench →

OBIO Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$32M$34M$3M$3M$4M—
Gross Profit$32M$33M$2M$3M$3M—
Operating Income (EBIT)($58M)($52M)($64M)($52M)($33M)—
Net Income($59M)($53M)($61M)($49M)($34M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OBIO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$0M$0M$31M$1M$1M——
Gross Profit$0M$0M$31M$1M$1M——
Operating Income (EBIT)($22M)($22M)$7M($20M)($19M)——
Net Income($24M)($21M)$6M($21M)($19M)——

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OBIO Free Cash Flow History

OBIO Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$115M$76M$95M$96M—
Total Liabilities$61M$43M$27M$43M—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OBIO viewer.

Other Companies in Biotechnology

← OBILAll “O” companiesOBK →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.